https://prabadinews.com/
Email
weborders@prabadincorp.com
Call us
+1 (786)-332-3938
Home
Blog
Latest Post
Product Catalog
X
Health
July 30, 2025
How Pharmacist-Led Initiatives Reduce Adverse Drug Events
Pharmacists share their institution’s individual, unique approaches to medication safety.
Health
July 30, 2025
Gedatolisib Doublet, Triplet Regimens Improve PFS in Patients With PIK3CA Wild-Type HR+/HER2– Breast Cancer
Emerging trial results reveal gedatolisib significantly enhances progression-free survival (PFS) in advanced HR+/HER2- breast cancer.
Health
July 30, 2025
Clinical Perspective: Lenacapavir Demonstrates 100% Efficacy in PURPOSE Trials for Twice-Yearly HIV PrEP
Namrata Shah, MD, highlights lenacapavir’s ease of use, long-acting protection, and the vital role pharmacists play in expanding equitable HIV…
Health
July 29, 2025
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
Experts discuss groundbreaking Hot Line trials at the European Society of Cardiology Congress 2025, offering insights into the latest cardiovascular…
Health
July 29, 2025
Study Evaluates Financial Implications, Socioeconomic Profile of Patients With Diabetes
A new study reveals that individuals with type 2 diabetes (T2D) face significant financial hardships, impacting their health and medication…
Health
July 29, 2025
FDA Approves Pegcetacoplan to Reduce Proteinuria in 2 Kidney-Related Diseases
The treatment proved efficacy across all 3 key markers of C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN).
Health
July 29, 2025
EHA 2025: Golcadomide Shows Deep Responses in High-Risk Follicular Lymphoma
Julio C. Chavez, MD, MS, discusses the distinct pharmacologic profile, clinical activity, and outpatient potential of golcadomide plus rituximab in…
Health
July 29, 2025
FDA Restricts Elevidys Use Amidst New Safety Concerns
FDA places clinical hold on Sarepta’s Elevidys gene therapy after safety concerns, but ambulatory patients regain access amid ongoing investigations.
Health
July 29, 2025
Tildrakizumab Improves Signs, Symptoms of Active Psoriatic Arthritis in Phase 3 Studies
Tildrakizumab 100 mg shows significant efficacy in treating psoriatic arthritis, achieving key clinical trial end points and offering hope for…
Health
July 29, 2025
High Burden of Pneumococcal Disease Found in Older Adults With Underlying Medical Conditions
Data from a retrospective study of adults in France found the highest incidence of pneumococcal disease in patients with the…
1
...
27
28
29
30
31
...
83